271 related articles for article (PubMed ID: 26870717)
1. Bisphosphonate-related osteonecrosis of the jaw in metastatic breast cancer patients: a review of 25 cases.
Kim HJ; Park TJ; Ahn KM
Maxillofac Plast Reconstr Surg; 2016 Dec; 38(1):6. PubMed ID: 26870717
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.
Vescovi P; Nammour S
Minerva Stomatol; 2010 Apr; 59(4):181-203, 204-13. PubMed ID: 20360666
[TBL] [Abstract][Full Text] [Related]
3. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
Assael LA
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
[TBL] [Abstract][Full Text] [Related]
4. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307).
Kizub DA; Miao J; Schubert MM; Paterson AHG; Clemons M; Dees EC; Ingle JN; Falkson CI; Barlow WE; Hortobagyi GN; Gralow JR
Support Care Cancer; 2021 May; 29(5):2509-2517. PubMed ID: 32929540
[TBL] [Abstract][Full Text] [Related]
6. Usability of surgical treatment in cases of bisphosphonate-related osteonecrosis of the jaw stage 2 with sequestrum.
Fukushima Y; Enoki Y; Nakaoka C; Okubo M; Kokabu S; Nojima J; Sato T; Yoda T
Ann Maxillofac Surg; 2015; 5(1):67-70. PubMed ID: 26389037
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw With Plasma Rich in Growth Factors After Dental Implant Surgery: A Case Report.
Gil IG; Ponte BM; Mateo ST; García JJ
J Oral Implantol; 2019 Aug; 45(4):289-296. PubMed ID: 31207196
[TBL] [Abstract][Full Text] [Related]
8. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
[TBL] [Abstract][Full Text] [Related]
9. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
Otto S; Tröltzsch M; Jambrovic V; Panya S; Probst F; Ristow O; Ehrenfeld M; Pautke C
J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
Grant BT; Amenedo C; Freeman K; Kraut RA
J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
[TBL] [Abstract][Full Text] [Related]
11. Novel insight into the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ).
Kishimoto H; Noguchi K; Takaoka K
Jpn Dent Sci Rev; 2019 Nov; 55(1):95-102. PubMed ID: 31193410
[TBL] [Abstract][Full Text] [Related]
12. [Bilateral maxillary bisphosphonate-related osteonecrosis of the jaw: a case report].
Meng PQ; Guo YX
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 49(6):1098-1102. PubMed ID: 29263490
[TBL] [Abstract][Full Text] [Related]
13. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
Carlson ER; Basile JD
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
[TBL] [Abstract][Full Text] [Related]
14. Dental extraction as a risk factor for bisphosphonate related osteonecrosis of the jaw in cancer patients: an update.
Utreja A; Almas K; Javed F
Odontostomatol Trop; 2013 Jun; 36(142):38-46. PubMed ID: 24073539
[TBL] [Abstract][Full Text] [Related]
15. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
O'Ryan FS; Lo JC
J Oral Maxillofac Surg; 2012 Aug; 70(8):1844-53. PubMed ID: 22595135
[TBL] [Abstract][Full Text] [Related]
17. Dental implant treatment after healing of bisphosphonate-related osteonecrosis of the jaw (BRONJ) in the same region: a case report.
Kim JW; Baik J; Jeon JH
J Korean Assoc Oral Maxillofac Surg; 2016 Jun; 42(3):157-61. PubMed ID: 27429938
[TBL] [Abstract][Full Text] [Related]
18. Osteonecrosis of the jaw after implant surgery in patients treated with bisphosphonates--a presentation of six consecutive cases.
Tam Y; Kar K; Nowzari H; Cha HS; Ahn KM
Clin Implant Dent Relat Res; 2014 Oct; 16(5):751-61. PubMed ID: 23445465
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients.
Thumbigere-Math V; Sabino MC; Gopalakrishnan R; Huckabay S; Dudek AZ; Basu S; Hughes PJ; Michalowicz BS; Leach JW; Swenson KK; Swift JQ; Adkinson C; Basi DL
J Oral Maxillofac Surg; 2009 Sep; 67(9):1904-13. PubMed ID: 19686928
[TBL] [Abstract][Full Text] [Related]
20. Pathologic fractures in bisphosphonate-related osteonecrosis of the jaw-review of the literature and review of our own cases.
Otto S; Pautke C; Hafner S; Hesse R; Reichardt LF; Mast G; Ehrenfeld M; Cornelius CP
Craniomaxillofac Trauma Reconstr; 2013 Sep; 6(3):147-54. PubMed ID: 24436752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
